Abstract WP082: Prognostic Value of Cardiac Troponin I in Acute Ischemic Stroke Patients Treated with Thrombolytic Therapy.

Background: Cardiac troponin is a well-established diagnostic and prognostic marker in coronary heart disease. We investigated its prognostic value in acute ischemic stroke (AIS) patients treated with thrombolytic therapy. Methods: We conducted a retrospective observational study of AIS patients treated with thrombolytics at Southern Illinois Healthcare between 2017 and 2024. Demographics, clinical, laboratory, and radiographic data were collected. Outcomes included symptomatic intracranial hemorrhage (sICH), in-hospital mortality, and mRS at 30 days. Patients were divided by admission cardiac troponin I (cTnI) levels. Multivariable logistic regression was used to evaluate the association between cTnI and predetermined outcomes. Statistical significance was set at p